Accelerating the pulse of cardiovascular R&D

Nature Reviews Drug Discovery

Volumn 9, Issue 11, 2010, Pages 823-824

  Plump, Andrew ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; MINERALOCORTICOID ANTAGONIST; THROMBIN INHIBITOR; WARFARIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; INVESTMENT; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NOTE; PHARMACOGENETICS; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; THROMBOSIS;

CARDIOVASCULAR DISEASES; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PULSE; RESEARCH;

EID: 78049459078     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3315     Document Type: Note

References (8)

1. Garber, A. M. An uncertain future for cardiovascular drug development? N. Engl. J. Med. 360, 12 (2009).
2. World Health Organization. Cardiovascular diseases (CVDs), [online] http://www.who.int/mediacentre/factsheets/fs317/en/index.html (2009)
3. Yang, W. et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 362,1090-1101 (2010).
4. FDA approves updated warfarin (Coumadin) prescribing information. [online]. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2007/ ucm108967.htm (2007).
5. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
6. Calhoun, D. A. et al. Resistant hypertension: diagnosis, evaluation, treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51,1403-1419 (2008).
7. Amar, L. et al. Aldosterone synthase inhibition with LCI699. A proof-of-concept study in patients with primary aldosteronism. Hypertension 13 Sep 2010 (doi: 10.1161/ HYPERTENSIONAHA.110.157271).
8. Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151 (2009).